Search

Author/Creator Gallagher, Stuart J.

1. C57BL/6 congenic mouse NRASQ61K melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo. (15th July 2019)

Authors:
Petit, Valérie; Raymond, Jeremy; Alberti, Christophe; Pouteaux, Marie; Gallagher, Stuart J.; Nguyen, Mai Q.; Aplin, Andrew E.; Delmas, Véronique; Larue, Lionel
Journal:
Pigment cell & melanoma research
Issue:
Volume 32:Number 6(2019)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Control of NF‐kB activity in human melanoma by bromodomain and extra‐terminal protein inhibitor I‐BET151. (3rd July 2014)

Authors:
Gallagher, Stuart J.; Mijatov, Branka; Gunatilake, Dilini; Gowrishankar, Kavitha; Tiffen, Jessamy; James, Wilmott; Jin, Lei; Pupo, Gulietta; Cullinane, Carleen; McArthur, Grant A.; Tummino, Peter J.; Rizos, Helen; Hersey, Peter
Journal:
Pigment cell & melanoma research
Issue:
Volume 27:Number 6(2014:Nov.)
Page Start:
1126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. HDAC inhibitors restore BRAF‐inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma. Issue 9 (20th December 2017)

Authors:
Gallagher, Stuart J.; Gunatilake, Dilini; Beaumont, Kimberley A.; Sharp, Danae M.; Tiffen, Jessamy C.; Heinemann, Anja; Weninger, Wolfgang; Haass, Nikolas K.; Wilmott, James S.; Madore, Jason; Ferguson, Peter M.; Rizos, Helen; Hersey, Peter
Journal:
International journal of cancer
Issue:
Volume 142:Issue 9(2018)
Page Start:
1926
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗